glp-1 drugs and inflammation Agonists - What is it? Anti-Inflammatory Effects of GLP-1-Based Therapies
Description
A.AnderssonA.-M
In some of the PIONEER trials, for example, urinary albumintocreatinine ratio data were not collected
Zhang Q, Delessa CT, Augustin R, Bakhti M, Colldn G, Drucker DJ, et al
This is precisely where knowing your genetic baseline changes the conversation entirely
One of the first reports offering real-world data on GLP-1 efficacy found that people using the medicines had lost an average of about 1.4% of their starting body weight after three months, which steadily increased to an average of about 3% weight loss after a full year on the treatment
